Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients

Coinfection with hepatitis C virus (HCV) and HIV is an increasingly recognized clinical dilemma, particularly since the advent of highly active antiretroviral therapy. Several studies of this population have demonstrated both more rapid progression of liver disease and poorer overall prognosis compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhillon, Ravinder, Rossi, Simona, Herrine, Steven K
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621394/
https://www.ncbi.nlm.nih.gov/pubmed/19209261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621394/
https://www.ncbi.nlm.nih.gov/pubmed/19209261

Ejemplares similares